Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Transient autoimmune hyperthyroidism following the withdrawal of Natalizumab in patients with multiple sclerosis.
A Systematic Review of Pharmacological Pain Management in Multiple Sclerosis.
Is Neuromyelitis Optica with Advanced Age of Onset a Paraneoplastic Disorder?
Established and novel disease-modifying treatments in multiple sclerosis.
Heat shock proteins and hormesis in the diagnosis and treatment of neurodegenerative diseases.
Circulating Levels of Interleukin-35 in Patients with Multiple Sclerosis: Evaluation of the Influences of FOXP3 Gene Polymorphism and Treatment Program.
Immune Responses to Non-Tumor Antigens in the Central Nervous System.
Trace elements in scalp hair samples from patients with relapsing-remitting multiple sclerosis.
Therapeutic promises of 2-methoxyestradiol and its drug disposition challenges.
Contribution of CD8 T lymphocytes to the immuno-pathogenesis of multiple sclerosis and its animal models.
Neuromyelitis optica-like pathology is dependent on Type I interferon response.
Current and emerging therapies for multiple sclerosis.
Association between Smoking and Health Outcomes in Postmenopausal Women Living with Multiple Sclerosis.
Outcome measures in multiple sclerosis.
[LINGO-1 Expression of brain tissue in Experimental Autoimmune Encephalomyelitis Mouse].
The role of antiproliferative gene Tob1 in the immune system.
Estimation of the multiple sclerosis risk in population living on contaminated territories after the Chornobyl catastrophe.
Pannexin1 Channels Are Required for Chemokine-Mediated Migration of CD4+ T Lymphocytes: Role in Inflammation and Experimental Autoimmune Encephalomyelitis.
Participant perceptions of a novel physiotherapy approach ("Blue Prescription") for increasing levels of physical activity in people with multiple sclerosis: a qualitative study following intervention.
[The metabolic abnormalities in plaques of multiple sclerosis patients - the assessment in proton MR spectroscopy (1HMRS)].
Respiratory tract rather than cutaneous atopic allergy inversely associate with multiple sclerosis: A case-control study.
Age of the Donor Reduces the Ability of Human Adipose-Derived Stem Cells to Alleviate Symptoms in the Experimental Autoimmune Encephalomyelitis Mouse Model.
The gateway theory: How regional neural activation creates a gateway for immune cells via an inflammation amplifier.
Immunodetection of outer membrane proteins by flow cytometry of isolated mitochondria.
Placebo and nocebo effects in the neurological practice.
Pages
« first
‹ previous
…
524
525
526
527
528
529
530
531
532
…
next ›
last »